Caricamento...
Targeting Akt in cell transfer immunotherapy for cancer
Pharmacologic inhibitors of the serine/threonine kinase Akt, initially aimed at deranged oncogenic pathways in tumors, have recently been shown to act as immunomodulators that markedly enhance the antitumor properties of T cells. Repurposing Akt inhibitors to improve antitumor immunity may be viewed...
Salvato in:
| Pubblicato in: | Oncoimmunology |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5048755/ https://ncbi.nlm.nih.gov/pubmed/27757294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1014776 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|